HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.77
Sakop ng araw
$0.81 - $0.88
Sakop ng taon
$0.51 - $0.88
Market cap
38.90M CAD
Average na Volume
37.16K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.44M | 68.19% |
Net na kita | -1.41M | -98.55% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.01M | -45.43% |
Kabuuang asset | 3.13M | -44.92% |
Kabuuang sagutin | 993.58K | 188.33% |
Kabuuang equity | 2.14M | — |
Natitirang share | 46.31M | — |
Presyo para makapag-book | 15.40 | — |
Return on assets | -100.84% | — |
Return on capital | -128.95% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.41M | -98.55% |
Cash mula sa mga operasyon | -829.86K | 58.42% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -833.37K | 46.32% |
Malayang cash flow | -316.04K | 82.62% |
Tungkol
Itinatag
2018
Headquarters
Website
